The U.S. Food and Drug Administration has approved Merck & Co.’s KEYTRUDA QLEX, a subcutaneous injection for adult patients ...

The companies began their collaboration on WIDAPLIK in December 2018, when the formulation was developed at Piramal’s site in ...

Enzene has announced the commercial supply of pertuzumab, a monoclonal antibody (mAb) therapy indicated for the treatment of ...

Bristol Myers Squibb (BMS) has committed to Veeva Vault CRM, part of the Vault CRM Suite of applications that provide the ...

Evonik has launched MaxiPure Polysorbate 80, a highly pure surfactant designed for injectable and biopharmaceutical ...

Pfizer has agreed to acquire Metsera, a clinical-stage biopharma company accelerating medicines for obesity and ...

Incyte named Dave Gardner Executive Vice President and Chief Strategy Officer (CSO) effective September 22, 2025. In his new ...

The groninger Group has acquired Reinraumtechnik Ulm GmbH, expanding its technological portfolio and strengthening its ...

Therapeutic proteins, such as monoclonal antibodies (mAbs), are increasingly used in injectable formulations to treat a wide ...

As the demand for cell and gene therapies continues to grow around the world, Cryoport Systems is investing in infrastructure ...

Pegozafermin offers a distinct mechanism of action with potential for enhanced efficacy and tolerability and opportunities ...

Explore recent issues of Contract Pharma covering key industry trends. Read the full digital version of our magazine online.